AU4301001A - Modified labeled complement components for immunoassays - Google Patents

Modified labeled complement components for immunoassays

Info

Publication number
AU4301001A
AU4301001A AU43010/01A AU4301001A AU4301001A AU 4301001 A AU4301001 A AU 4301001A AU 43010/01 A AU43010/01 A AU 43010/01A AU 4301001 A AU4301001 A AU 4301001A AU 4301001 A AU4301001 A AU 4301001A
Authority
AU
Australia
Prior art keywords
immunoassays
complement components
labeled complement
modified labeled
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43010/01A
Other languages
English (en)
Inventor
Stanley Paul Racis
Steve Sinka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagen Corp
Original Assignee
Diagen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagen Corp filed Critical Diagen Corp
Publication of AU4301001A publication Critical patent/AU4301001A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76Chemiluminescence; Bioluminescence
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Plasma & Fusion (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
AU43010/01A 1999-12-16 2000-10-05 Modified labeled complement components for immunoassays Abandoned AU4301001A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17116199P 1999-12-16 1999-12-16
US60171161 1999-12-16
PCT/US2000/041081 WO2001044499A1 (fr) 1999-12-16 2000-10-05 Composants du complement marque modifie pour immunodosages

Publications (1)

Publication Number Publication Date
AU4301001A true AU4301001A (en) 2001-06-25

Family

ID=22622777

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43010/01A Abandoned AU4301001A (en) 1999-12-16 2000-10-05 Modified labeled complement components for immunoassays

Country Status (2)

Country Link
AU (1) AU4301001A (fr)
WO (1) WO2001044499A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105301235A (zh) * 2015-11-16 2016-02-03 北京中航赛维生物科技有限公司 一种使用磁微粒化学发光定量检测抗核小体抗体IgG的试剂盒及其制备方法和检测方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005007893A2 (fr) * 2003-07-10 2005-01-27 Blind Pig Proteomics, Inc. Detection universelle de liaison

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5035995A (en) * 1984-10-02 1991-07-30 Calpis Food Industry Co., Ltd. Test method involving substance-conjugated complement component C1q

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105301235A (zh) * 2015-11-16 2016-02-03 北京中航赛维生物科技有限公司 一种使用磁微粒化学发光定量检测抗核小体抗体IgG的试剂盒及其制备方法和检测方法

Also Published As

Publication number Publication date
WO2001044499A9 (fr) 2002-06-06
WO2001044499A1 (fr) 2001-06-21
WO2001044499B1 (fr) 2002-05-10

Similar Documents

Publication Publication Date Title
AU1290001A (en) Antibodies
AU4935000A (en) Antibodies
AU7448600A (en) High sensitive immunoassay
AU2678800A (en) Modified calycins
AU2934699A (en) Demoludator circuits
AU9750398A (en) D-homo-9,10-secocholesta-23-yne-3,25-diol derivatives
AU4228900A (en) Autofocus z stage
AU7302000A (en) Phase change mechanism
AU3344399A (en) Remedies for primary biliary cirrhosis
AU1262100A (en) Bisphenyl thiocompounds
AU5749800A (en) Fragrance-bearing toner
AU6330399A (en) Semiconductor structure for semiconductor components
AU4301001A (en) Modified labeled complement components for immunoassays
AU7650398A (en) Splitter gate
AU3821800A (en) Auxiliary device for serving
AU3414700A (en) Centrifuge
AU1465901A (en) Operating arrangement for mechanism
AU4916800A (en) Photosensitive composition
AU2659800A (en) Electromechanical component
AU6567400A (en) Substituted 2-imino-thiazolines
AU6487298A (en) Underwear for men
AU5235600A (en) Assays
AU7624000A (en) Wrist-worn radiotelephone arrangement
AU6010699A (en) Apc-2
AU8386598A (en) Systemin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase